Nimit Rajesh Ghatalia files SEBI Takeover Regulation 31(4) disclosure with NSE for Aarey Drugs & Pharmaceuticals

Regulatory 6 Jul 2026 · Filed / open· ✓ Verified

Nimit Rajesh Ghatalia submitted a formal disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Regulation 31(4) to the NSE for Aarey Drugs & Pharmaceuticals Limited. The disclosure regime applies when a person acquires 5% or more of the voting capital of a listed company. The filing indicates completion of the acquisition and formal disclosure to the exchange; the specific stake percentage, consideration, and any concert party relationships remain within the filed document.

Why it mattersRegulation 31(4) disclosure marks the formal regulatory trigger for substantial share acquisition; the acquirer's identity and filing timing establish compliance with the 2-working-day disclosure window post-acquisition.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals